Simultaneous high-performance liquid chromatographic determination of carbamazepine and its principal metabolites in human plasma and urine. 1988

R D Chelberg, and S Gunawan, and D M Treiman
Neurology Service, Veterans Administration West Los Angeles Medical Center, California.

A rapid high-performance liquid chromatographic method is described for the simultaneous determination of carbamazepine and the 10,11-epoxide, 10,11-dihydroxy, and 2-hydroxy metabolites of carbamazepine. The chromatographic system involves the use of a 18C-microsorb, reversed-phase column with acetonitrile/water (28:72) as the mobile phase. Detection and quantitation are monitored by ultraviolet absorption at 212 nm. The compounds are extracted from 250 microliters of plasma or from 100 microliters urine with methyl-t-butyl ether and 0.1 M sodium hydroxide; 2-methylcarbamazepine is added as internal standard. If phenytoin and/or phenobarbital are present in plasma or urine samples, it is necessary to use 1.0 M sodium hydroxide. The limits of quantitation for carbamazepine and its metabolites are 10 ng/ml.

UI MeSH Term Description Entries
D002220 Carbamazepine A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. Amizepine,Carbamazepine Acetate,Carbamazepine Anhydrous,Carbamazepine Dihydrate,Carbamazepine Hydrochloride,Carbamazepine L-Tartrate (4:1),Carbamazepine Phosphate,Carbamazepine Sulfate (2:1),Carbazepin,Epitol,Finlepsin,Neurotol,Tegretol
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

R D Chelberg, and S Gunawan, and D M Treiman
November 1980, Journal of pharmaceutical sciences,
R D Chelberg, and S Gunawan, and D M Treiman
May 1984, Clinical chemistry,
R D Chelberg, and S Gunawan, and D M Treiman
September 1984, Journal of pharmaceutical sciences,
R D Chelberg, and S Gunawan, and D M Treiman
February 1981, Journal of chromatography,
R D Chelberg, and S Gunawan, and D M Treiman
September 1983, Journal of pharmaceutical sciences,
R D Chelberg, and S Gunawan, and D M Treiman
November 1987, Journal of chromatography,
R D Chelberg, and S Gunawan, and D M Treiman
September 1984, Journal of chromatography,
R D Chelberg, and S Gunawan, and D M Treiman
April 1997, Journal of chromatography. B, Biomedical sciences and applications,
R D Chelberg, and S Gunawan, and D M Treiman
November 1992, Journal of chromatography,
Copied contents to your clipboard!